Blog - Page 566 of 5683 - QualityStocks

TuesdayJan 16, 2024 2:37 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today outlined key accomplishments from 2023 and provided key strategic priorities for 2024. “In 2023, we experienced significant progress in both InMed’s pharmaceutical drug development and in BayMedica’s health and wellness initiatives. Our primary accomplishments throughout the year included a number of key milestones, such as the completion of a phase 2 clinical trial and the launch of two new preclinical programs targeting the treatment of Alzheimer’s disease and age-related macular degeneration (‘AMD’),” said Eric A. Adams, InMed president and CEO.…

TuesdayJan 16, 2024 2:25 pm

QualityStocksNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, has released a message for its shareholders from CEO Mark Dybul. In the message, Dybul provides an update about key developments the company experienced during 2023, including signing a definitive agreement to combine with the European-based, cutting-edge artificial-intelligence (“AI”) company GEDi Cube; GEDi Cube’s partnership with NVIDIA to expand its multiomic capabilities to multimodal; and consistently achieving “the holy grail of cancer research” in preclinical studies. The company has also scheduled a shareholder meeting on Jan. 25, 2024, to vote…

TuesdayJan 16, 2024 2:13 pm

QualityStocksNewsBreaks — Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Reports Significant Assay Results at Saskatchewan Project, Upgraded Results in Brazil Project

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element and uranium sectors, has announced initial geochemical assay results from its 2023 drilling program; the program was conducted on the Magnet Ridge Zone at Appia’s Alces Lake Project in northern Saskatchewan. According to the announcement, these significant findings “mark a pivotal milestone” in the company's focus and commitment to advance exploration and development initiatives within the prolific Athabasca Basin area. Highlights of the report include returned assays of up to 1.57 wt.% (15,700 ppm) total rare earth oxides (“TREO”), with…

TuesdayJan 16, 2024 1:12 pm

QualityStocksNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR) Selected by Navix Health in ‘Significant Milestone’ Collaboration Advancing Digital Health

SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, has been selected as an exclusive alcohol data partner by Navix Health, a leading provider of innovative healthcare technologies. Navis Health made the announcement last week. According to the announcement, Navix Health will be integrating SOBRsafe's transdermal detection solutions into its proprietary Navix Hub(TM), which is a fully unified facility and practice management software for behavioral health. “With the integration of the SOBRsafe technology, Navix Hub customers can augment current operations with touch-based alcohol monitoring, the results flowing directly into their client records platform,” the announcement stated. “This collaboration marks…

TuesdayJan 16, 2024 11:15 am

InvestorBrandNetwork Highlights PaxMedica Inc.’s (NASDAQ: PXMD) Video Release on Transformative ASD Study

In a significant development for the neurological disorder community, PaxMedica (NASDAQ: PXMD) has released an insightful video detailing the outcomes of its Phase 2 study on Autism Spectrum Disorder (“ASD”), initially published in the Annals of General Psychiatry. This pivotal video highlights the research led by Chief Medical Officer Dr. David Hough and a team of ASD experts, and the potential of low-dose suramin intravenous infusions as a breakthrough treatment for ASD. The study, a comprehensive 14-week randomized, double-blind, placebo-controlled trial, enrolled 52 boys aged 4–15 years with moderate to severe ASD. Focused on evaluating the efficacy and safety of…

TuesdayJan 16, 2024 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Doubling Down on Separation and Refining of Critical Metals Amid China’s Ban on Export of Rare Earth Technology

Ucore, a company engaged in the exploration for and separation and scalable production of REEs in Canada and the US, views China’s recent ban on the export of technology to produce rare earth permanent magnets as an opportunity Through this ban, the company looks to grow and assert its dominance in the sector, all while doing away with dependence on China This is made possible by its RapidSX(TM) technology, which it has been slowly perfecting It is also made possible by its Demonstration Program, along with its Louisianna facility that sets it on track to separating friendly REEs and OEMs…

TuesdayJan 16, 2024 9:45 am

SuperCom Ltd. (NASDAQ: SPCB) PureSecurity Electronic Monitoring Suite: A Cost-Effective Solution for Domestic Violence Offender Monitoring

Agencies and nonprofits serving domestic violence victims are seeing an increase in victim numbers With typical pressures on funding, governments require a cost-effective solution that can help keep victims safe while maintaining supervision of domestic violence offenders under court-ordered supervision SuperCom's PureSecurity electronic monitoring suite offers governments a cost-effective solution for monitoring offenders through GPS monitoring, home detention, domestic violence prevention, and more SuperCom (NASDAQ: SPCB), a provider of secured solutions for the e-government, IoT, and cybersecurity sector, is on a mission to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services. The…

TuesdayJan 16, 2024 9:00 am

SOBRsafe Inc. (NASDAQ: SOBR) Is ‘One to Watch’

$25 million paid in capital First-to-market, innovative detection technology – hardware + SaaS Traction established and clear expansion path in three mega markets Integration, licensing and white labelling could accelerate trajectory Robust IP protection SOBRsafe (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry. Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for…

FridayJan 12, 2024 3:30 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Grow Revenue and Commercial Opportunities Through Licensing

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is committed to providing healthier delivery methods of drugs and other active pharmaceutical ingredients (“APIs”) through its patented drug delivery technology, DehydraTECH(TM). “The company’s efforts have focused on several key segments, including hypertension, diabetes, antivirals, epilepsy, nicotine replacement, and more. This has been an ongoing process since 2016, with positive results achieved from various clinical studies thus far, showing up to 17x brain absorption improvements for oral administration of APIs… Human clinical studies have been conducted since 2018, with more on the way,” a recent article reads. “With…

FridayJan 12, 2024 3:00 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Positioned as Go-to Logistics Solution Within USMCA Region

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company reforming cross-border shipping, recently announced the renewed selection of its Fr8App for Amazon Mexico’s domestic shipping within the USMCA region. “This marks the second year that Amazon Mexico has contracted Fr8Tech, in what the CEO Javier Selgas has attributed to the company’s commitment to meeting customers’ needs and continuously improving its platform. This announcement comes just months after Fr8Tech announced the securing of a Request for Quotation (‘RFQ’) from a leading global pharmaceutical giant, for which it was awarded 33 lanes to transport pharmaceutical goods from the U.S. to both Mexico and…

Site Search

Company Search